This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidson, P. W.
Right arrow Articles by Weiss, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidson, P. W.
Right arrow Articles by Weiss, B.
Related Collections
Right arrow Therapeutics & Toxicology
PEDIATRICS Vol. 113 No. 4 April 2004, pp. 1023-1029

SUPPLEMENT ARTICLE

Mercury Exposure and Child Development Outcomes

Philip W. Davidson, PhD, Gary J. Myers, MD and Bernard Weiss, PhD

From the University of Rochester School of Medicine and Dentistry, Rochester, New York

Mercury is ubiquitous in the global environment, ensuring universal exposure. Some forms of mercury are especially neurotoxic, including clinical signs at high doses. However, typical human exposures occur at low to moderate doses. Only limited data about neurotoxicity at low doses are available, and scientists differ in their interpretation. Dose–response data on neurodevelopment are particularly limited. Despite or perhaps because of the lack of sufficient or consistent scientific data, public concern about a link between mercury exposure and developmental disabilities has been rising. After reviewing the data, the US Environmental Protection Agency proposed a reference dose (an estimate of a daily dose that is likely to be without a risk of adverse effects over a lifetime) for methyl mercury that is substantially lower than previous guidelines from the World Health Organization, the US Agency for Toxic Substances and Disease Registry, and the US Food and Drug Administration. Some questions have been raised about the Environmental Protection Agency’s guidelines, but the issue remains unresolved. Meanwhile, consumer groups have raised questions about the potential link between mercury exposure and autism spectrum disorders as well as other adverse neurodevelopmental outcomes. This hypothesis has prompted some parents to seek regulatory, legal, or medical remedies in the absence of firm evidence. This article reviews what is known about mercury neurotoxicity and neurodevelopmental risk. Our intent is to focus the debate about mercury on 1) additional research that should be sought and 2) defining the principal issues that public policy makers face.

Key Words: mercury • developmental neurotoxicity • child neurocognitive development

Abbreviations: MeHg, monomethyl mercury • EPA, Environmental Protection Agency • CNS, central nervous system • SCDS, Seychelles Child Development Study • PCB, polychlorinated biphenyl • NRC, National Research Council

Received for publication Oct 7, 2003; Accepted Oct 20, 2003.




This article has been cited by other articles:


Home page
 Toxicol SciHome page
R. F. Berman, I. N. Pessah, P. R. Mouton, D. Mav, and J. Harry
Low-Level Neonatal Thimerosal Exposure: Further Evaluation of Altered Neurotoxic Potential in SJL Mice
Toxicol. Sci., February 1, 2008; 101(2): 294 - 309.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
N. Onishchenko, C. Tamm, M. Vahter, T. Hokfelt, J. A. Johnson, D. A. Johnson, and S. Ceccatelli
Developmental Exposure to Methylmercury Alters Learning and Induces Depression-like Behavior in Male Mice
Toxicol. Sci., June 1, 2007; 97(2): 428 - 437.
[Abstract] [Full Text] [PDF]